July 30, 2024
Researchers have identified mouse brain regions vulnerable to blood vessel degeneration, offering clues to the connection between vasculature and neurodegenerative disease.
New high-resolution 3D maps show how the brain's blood vessels changes with age
July 30, 2024
Researchers have developed a model that more accurately predicts how genetics and air pollution levels causally influence disease development.
Genes or environment? A new model for understanding disease risk factors
July 29, 2024
The Childbirth Experience Questionnaire (CEQ2) was used to investigate how medical interventions influence the individual birth experience. The overall experience was rated positively.
July 29, 2024
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study. The preclinical study combined the analysis of human ovarian tumors and animal models of the disease.
July 29, 2024
New research using live mouse-adapted influenza virus improves upon previous mouse experiments to explain how maternal infection impacts fetal brain development. The study also indicates fetal brain changes are more likely once the severity of the mother's infection meets a specific threshold
Fetal brain impacted when mom fights severe flu: New mouse study explains how
July 29, 2024
If current guidelines for cholesterol and high blood pressure treatment remain unchanged, a newly unveiled heart risk calculator would render 16 million people ineligible for preventive therapy. Loss of eligibility for cholesterol and blood pressure medicines could lead to 107,000 more heart attacks and strokes over 10 years but may reduce new diabetes cases by 57,000 over the same period. The findings underscore the importance of reexamining current treatment cutoffs in parallel with new risk estimates to better individualize therapy and improve clinical decisions.
What will the new cardiovascular risk calculator mean for patients?
July 24, 2024
For patients with Afib, using a wearable device can lead to higher rates of anxiety about their Afib symptoms and treatment, doctor visits, and use of informal healthcare resources, according to a new study.
July 23, 2024
Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. The analysis of outcomes from more than 300 pregnancies and infants will be presented at the 2024 International AIDS Conference (AIDS 2024) in Munich, Germany.
Long-Acting Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy
July 22, 2024
A new machine-learning model can identify the stage of disease in ductal carcinoma in situ, a type of preinvasive tumor that can sometimes progress to a deadly form of breast cancer. This could help clinicians avoid overtreating patients whose disease is unlikely to progress.
AI model identifies certain breast tumor stages likely to progress to invasive cancer
July 22, 2024
A new compound shows promise in overcoming chemotherapy resistance in triple-negative breast cancer -- and could potentially be applied to fibrotic conditions like liver fibrosis or pulmonary fibrosis.
Team marks milestone in progress toward investigational new drug for triple-negative breast cancer
